维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Alagona P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Beyond LDL cholesterol : the role of elevated triglyc- erides and low HDL cholesterol in residual CVD risk remaining af- ter statin therapy显示文摘	Alagona P Jr	2009	Am J Manag Care2009，15，3：	1
2	Post-stroke reorganization of hand motor area:a 1-year prospective follow-up with focal transcranial magnetic stimulation显示文摘	Delvaux V Alagona G Gerard P	2003	Clin Neurophysiol2003，114，7：	1
3	Post-stroke reorganization of hand motor area : a 1-year prospective follow- up with focal transcranial magnetic stimulation 显示文摘	Delvaux V Alagona G Gerard P	2003	Clin Neurophysiol2003，114，7：	1
4	Nuclear magnetic resonance imaging in a patient with a DDD pacemaker显示文摘	Alagona P Jr Toole J C Maniscalco B S	1989	Pacing Clin Electrophysiol1989，12，4：	1
5	Equivalent efficy of a time-release form of niacin(niaspan) given once-night versus plain niacin in the management of hyperlipidemia显示文摘	Knopp RH Alagona P Davidson M	1998	Metabolism1998，47，9：	1
6	Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia显示文摘	Alagona P Jr Capuzzi DM	2000	Am J Cardiol2000，85，9：	1
7	Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia显示文摘	Goldberg A Alagona P Capuzzi D	2000	Am J Cardiol2000，85，：	1
8	Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy 显示文摘	Alagona P	2009	Am J Manag Care2009，15，3：	1
9	Muhiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia显示文摘	Goldberg A Alagona P J Capuzzi D M	2000	Am J Cardiol2000，85，9：	1
10	Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy 显示文摘	ALAGONA P	2009	Am J Manag Care2009，15，3：	1
11	The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology显示文摘	Laslett LJ Alagona P Clark BA	2012	J Am Coll Cardiol2012，60，25：	1
12	Beyond LDL cholesterol:the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy显示文摘	Alagona P	2009	Am J Manag Care2009，15，3：	1
13	Beyond LDL cholesterol:the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy显示文摘	Alagona P	2009	Am J Manag Care2009，15，3：	1
14	Post-stroke reorganiza- tion of hand motor area: a 1-year prospective follow-up with fo- cal transcranial magnetic stimulation 显示文摘	Delvaux V Alagona G Gerard P	2003	Clin Neurophysiol2003，114，7：	1
15	Beyond LDL cholesterol:the role of devated triglycerides,and low HDL cholesterol in residual CVD) risk remaining after statin,therapy显示文摘	Alagona P Jr		0，，3：	1
16	Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia显示文摘	Alagona P Jr	2010	Vasc Health Risk Manag2010，6，6：	1
17	Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia显示文摘	Goldberg A Alagona P Capuzzi DM	2000	Am J Cardiol2000，85，9：	1
18	Equivalent efficacy of atime-release form of niacin(Niaspan)given once-a-night versus plain niacin in the management of hyperlipidemia显示文摘	Knopp RH Alagona P Davidmn M	1998	Metabolism1998，47，9：	1
19	Ipsilateral motor responses to focal transcranial magnetic stimulation in healthy subjects and acute-stroke patients显示文摘	Alagona G Delvaux V Gerard P	2001	Stroke2001，32，6：	1
20	Beyond LDL cholesterol the role of elevated triglycerilesand low HDL cholesterol in residual CVD risk remaining after statintherapy显示文摘	Alagona P	2009	Am J Manag Care2009，15，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示